Rosemary Kane
- Molecular Biology
- Ophthalmology top 5%
- Pulmonary and Respiratory Medicine
- Radiology, Nuclear Medicine and Imaging
- Epidemiology
- Co-authors
- Colm O’BrienHelena LeeCatherine GodsonMichael P. KeaneJohn CreanNoëlynn OliverAurélie FabreSu Ling Ho
- Topics
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers)Extracellular vesicles in disease (2 papers)Connective Tissue Growth Factor Research (2 papers)
- Partner nations
- IrelandUnited StatesCanada
In The Last Decade
Rosemary Kane
15 papers receiving 443 citations
Peers
Comparison fields: 5 of 69
- Molecular Biology 208
- Ophthalmology 114
- Pulmonary and Respiratory Medicine 83
- Radiology, Nuclear Medicine and Imaging 82
- Epidemiology 60
Countries citing papers authored by Rosemary Kane
This map shows the geographic impact of Rosemary Kane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosemary Kane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosemary Kane more than expected).
Fields of papers citing papers by Rosemary Kane
This network shows the impact of papers produced by Rosemary Kane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosemary Kane. The network helps show where Rosemary Kane may publish in the future.
Co-authorship network of co-authors of Rosemary Kane
This figure shows the co-authorship network connecting the top 25 collaborators of Rosemary Kane. A scholar is included among the top collaborators of Rosemary Kane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosemary Kane. Rosemary Kane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 26 | |
| 3 | 0 | |
| 4 | 10 | |
| 5 | 31 | |
| 6 | 40 | |
| 7 | 9 | |
| 8 | 1 | |
| 9 | 44 | |
| 10 | 1 | |
| 11 | 82 | |
| 12 | Chordin-like 1, a bone morphogenetic protein-4 antagonist, is upregulated by hypoxia in human retinal pericytes and plays a role in regulating angiogenesis. | 43 |
| 13 | 81 | |
| 14 | 34 | |
| 15 | 7 | |
| 16 | 30 |
About Rosemary Kane
Rosemary Kane is a scholar working on Pulmonary and Respiratory Medicine, Ophthalmology and Immunology and Allergy, having authored 16 papers that have together received 447 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Extracellular vesicles in disease (2 papers) and Connective Tissue Growth Factor Research (2 papers). The work is most often cited by research in Ophthalmology (114 citations), Hepatology (40 citations) and Immunology and Allergy (22 citations). Rosemary Kane has collaborated with scholars based in Ireland, United States and Canada. Frequent co-authors include Colm O’Brien, Helena Lee, Catherine Godson, Michael P. Keane, John Crean, Noëlynn Oliver, Aurélie Fabre, Su Ling Ho, Abbot F. Clark and Julie C. Worrell. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology and European Respiratory Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.